|
|
|
Insider
Information: |
Szyman Catherine M |
Relationship: |
Director |
City: |
Minneapolis |
State: |
MN |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
123,190 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$2,365,284 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
123,190 |
|
|
Total
Value |
$2,365,284 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
4
|
Stock
price went up :
|
0
|
4
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
4.0
|
Percentage
Gain/Loss : |
0.0%
|
55.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Edwards Lifesciences Corp |
EW |
CVP, Critical Care |
2024-05-11 |
76,165 |
2019-08-30 |
0 |
Premium* |
|
Inari Medical, Inc. |
NARI |
Director |
2024-04-24 |
22,429 |
2020-05-27 |
0 |
Premium* |
|
Outset Medical, Inc. |
OM |
Director |
2023-05-31 |
24,596 |
2021-05-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
157 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2020-07-14 |
4 |
AS |
$67.66 |
$152,167 |
D/D |
(2,249) |
28,995 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2020-08-13 |
4 |
AS |
$78.24 |
$175,962 |
D/D |
(2,249) |
26,746 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care & Vascular |
|
2018-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,325 |
37,816 |
0 |
- |
|
NARI |
Inari Medical, Inc. |
Director |
|
2023-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
2,412 |
18,303 |
0 |
- |
|
NARI |
Inari Medical, Inc. |
Director |
|
2022-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
2,420 |
31,891 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-09-19 |
4 |
OE |
$66.86 |
$167,150 |
D/D |
2,500 |
20,138 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-09-19 |
4 |
AS |
$216.71 |
$541,775 |
D/D |
(2,500) |
17,638 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-10-25 |
4 |
AS |
$227.19 |
$567,975 |
D/D |
(2,500) |
17,105 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-10-25 |
4 |
OE |
$66.86 |
$167,150 |
D/D |
2,500 |
19,605 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-11-15 |
4 |
OE |
$66.86 |
$167,150 |
D/D |
2,500 |
19,605 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-11-15 |
4 |
AS |
$242.14 |
$605,350 |
D/D |
(2,500) |
17,105 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-12-16 |
4 |
OE |
$66.86 |
$167,150 |
D/D |
2,500 |
19,605 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-12-16 |
4 |
AS |
$234.27 |
$585,687 |
D/D |
(2,500) |
17,105 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2020-02-03 |
4 |
OE |
$66.86 |
$167,150 |
D/D |
2,500 |
19,389 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2020-02-03 |
4 |
AS |
$219.50 |
$548,750 |
D/D |
(2,500) |
16,889 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2020-02-18 |
4 |
AS |
$228.57 |
$571,425 |
D/D |
(2,500) |
16,889 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2020-02-18 |
4 |
OE |
$66.86 |
$167,150 |
D/D |
2,500 |
19,389 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-05-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,595 |
24,803 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care & Vascular |
|
2018-02-20 |
4 |
D |
$133.82 |
$355,827 |
D/D |
(2,659) |
31,773 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care & Vascular |
|
2017-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,725 |
46,528 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care & Vascular |
|
2016-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,750 |
34,570 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care & Vascular |
|
2016-02-19 |
4 |
D |
$86.24 |
$246,301 |
D/D |
(2,856) |
31,734 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care & Vascular |
|
2017-02-22 |
4 |
D |
$89.74 |
$259,438 |
D/D |
(2,891) |
43,637 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-02-19 |
4 |
D |
$177.78 |
$519,829 |
D/D |
(2,924) |
23,747 |
0 |
- |
|
OM |
Outset Medical, Inc. |
Director |
|
2021-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,288 |
10,035 |
0 |
- |
|
157 Records found
|
|
Page 3 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|